- Home
- Applications
- tumor tissue
Refine by
Tumor Tissue Product Applications
12 applications found
And with earlier detection comes the promise of a surgical cure—that is, the complete removal (or resection) of all tumor tissue from a patient. Research has shown that patients with surgical cures have fewer complications in recovery and a greatly enhanced survival rate when compared to patients who do not achieve surgical ...
ByAkrotome Imaging, Inc. based in Cleveland, OHIO (USA)
FIRE’s quenched, substrate-based probe (qSBP) technology guides surgeons by ensuring probe signal is only seen when cancer is detected, clearly delineating tumor tissue from healthy tissue and virtually eliminating spurious background fluorescence common in other probes. ...
ByAkrotome Imaging, Inc. based in Cleveland, OHIO (USA)
The ability to create large, RF lesions has multiple applications in soft tissue and tumor ablation. For example, there is a clear, unmet need in the market for the treatment of liver cancer. ...
ByThermedical, Inc. based in Waltham, MASSACHUSETTS (USA)
The long-standing, successful use of radio-theranostics in imaging and therapy is based on targeting radiolabeled molecules to tumors or other diseased tissues. Over 10,000 hospitals worldwide use radioisotopes for in-vivo diagnosis or treatment, reaching around 35 million patients each year. The ideal cancer imaging tool is a homogenous conjugate with a precisely defined payload-to-carrier ratio, showing specific tumor-targeting with minimal side-effects and fast ...
ByNavigo Proteins GmbH based in Halle, GERMANY
Level 1 evidence was found for bladder cancer, breast cancer, cervical cancer, cancer of the esophagus, lymph nodes of head and neck tumors, rectum cancer, soft tissue sarcoma, malignant melanoma, glioblastoma multiform, and various superficial ...
ByPyrexar based in Salt Lake City, UTAH (USA)
A critical factor in ensuring complete resection of a solid cancer tumor is the ability to determine where diseased tissue ends and healthy tissue begins. Our research, as well as our clinical collaborators, confirm that there is a pressing unmet clinical need: the ability to rapidly and globally assess the status of marginal tissue adjacent to a tumor while the patient is in the ...
ByAkrotome Imaging, Inc. based in Cleveland, OHIO (USA)
Premium
Hard tissues such as those from tumors can be particularly difficult to homogenize, and animal models are often used in cancer research. ...
ByBertin Technologies based in Montigny-le-Bretonneux, FRANCE
HSI offers a non-invasive tool with diagnostic and surgical applications. HSI can image human tissue, returning a number of key properties without the need for ionising radiation (e.g., X-ray or CT), large equipment (e.g., MRI), or the use of dyes to help differentiate between similarly coloured ...
ByLiving Optics based in Oxfordshire, UNITED KINGDOM
MarginProbe is an FDA-approved breakthrough in lumpectomy surgery that helps surgeons achieve optimum results during their procedures. A non-invasive medical device, MarginProbe examines excised tissue during lumpectomy surgery and can detect the presence or absence of cancer cells on the margins. This provides vital, real time information to surgeons when it matters ...
ByDilon Technologies Inc. based in Newport News, VIRGINIA (USA)
Despite the use of aggressive surgery and combination chemotherapy, lung cancer remains difficult to control and is the biggest killer among cancers at 154,000 annual US deaths. Lung cancer kills more people per year than prostate, pancreas, breast, and colon cancers combined. ...
ByQuench Medical Inc. based in St Paul, MINNESOTA (USA)
Pegloprastide (also known as AVB-620) has completed a Phase 2 registration trial for fluorescent detection of cancer during breast cancer surgery (NCT03113825), as well as a Phase 1b clinical trial in women undergoing breast cancer surgery ...
ByAvelas Biosciences based in La Jolla, CALIFORNIA (USA)
Aptamers are short strands of DNA or RNA with unique secondary and tertiary structures that enable highly selective binding to various types of targets. While aptamers are similar to antibodies in their ability to specifically bind with high affinity, there are some key differences between antibodies and aptamers which have prompted an increase in aptamer development projects. Several hot areas for aptamers, along with specific aptamer advantages, are outlined below. ...
ByBase Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA)